Imagine a breakthrough in cancer treatment where only malignant cells are targeted, sparing healthy host cells; or patients ...

Imagine a breakthrough in cancer treatment where only malignant cells are targeted, sparing healthy host cells; or patients with abnormal protein synthesis are treated to produce a healthy protein.

Imagine a breakthrough in cancer treatment where only malignant cells are targeted, sparing healthy host cells; or patients ...

They say that change takes time. Well, that's not the case for RNA. The small biological molecule acts like a switchboard ...

Researchers from the Huntington's Disease Center, UCL Queen Square Institute of Neurology, and UK DRI at UCL have taken major ...

CIRBP Family, Tumors, Molecular Mechanisms, RNA-Binding Proteins, Cellular Stress Share and Cite: Cai, Y. , Wang, T. and Zhan ...

During splicing, which occurs after transcription (i.e., the synthesis of RNA from a DNA template), the introns are removed and the exons are joined, or spliced together.

A new discovery offers hope for Huntington’s disease. This discovery provides hope that a DNA repair process may help slow or ...

AAV-Navβ1 gene therapy effectively reduces seizures and prolongs life in a mouse model of SCN1B-linked Dravet syndrome, ...

rcsi.ie Biomarkers are quantifiable indicators of disease. These surrogates should be specific, sensitive, predictive, robust and easily accessible. A major class of RNA described as non-coding RNA ...

Global biotechnology leader CSL and sa-mRNA pioneer Arcturus Therapeutics today announced that the European Commission has granted marketing authorization for KOSTAIVE® (ARCT-154), a self-amplifying ...

After hours: February 14 at 6:27:18 PM EST Loading Chart for RNA ...